Sorafenib extends PFS, but not OS, for HCC transcatheter arterial chemoembolisation Presented ByProf. Masatoshi Kudo, Kindai University, Osaka, Japan TrialPhase 2, TACTICS ConferenceASCO GI 2021 12 March, 2021 11:30
